Young et al. measured serum level of VEGF-D in patients with LAM, healthy controls and patients with other pulmonary diseases and found that serum levels of VEGF-D were significantly higher in the first group of patients (9). Here, VEGFD is linked to lymphangioleiomyomatosis.